Oslo, Norway, 19 September 2019, Photocure ASA (OSE: PHO) management will be
presenting at the Norne Securities Vekst & Verdi Aksjeseminar in Vilnius,
Lithuania on September 20 at 14:25 EEST/13:25 CEST.
The conference is sponsored by Norne Securities. The presentation will be posted
on www.photocure.com when held on September 20, 2019.
Company contact:
Erik Dahl
Chief Financial Officer
Tel: +47 450 55 000
Email: ed@photocure.com
About Photocure ASA
Photocure, The Bladder Cancer Company, delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, which makes
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com, www.hexvix.com or www.cysview.com